artesunic acid has been researched along with Skin Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, X; Wang, W; Zhang, S | 1 |
| Berköz, M; Keskin, S; Korkmaz, D; Krośniak, M; Özkan-Yılmaz, F; Özlüer-Hunt, A; Türkmen, Ö | 1 |
| Efferth, T; Ramacher, M; Umansky, V | 1 |
3 other study(ies) available for artesunic acid and Skin Neoplasms
| Article | Year |
|---|---|
Artesunate restrains the malignant progression of human cutaneous squamous cell carcinoma cells via the suppression of the PI3K/AKT pathway.
Topics: Apoptosis; Artesunate; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Movement; Cell Proliferation; Humans; Insulin-Like Growth Factor I; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Skin Neoplasms | 2022 |
Artesunate inhibits melanoma progression in vitro via suppressing STAT3 signaling pathway.
Topics: Antineoplastic Agents; Apoptosis; Artesunate; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Disease Progression; Humans; Melanoma; Signal Transduction; Skin Neoplasms; STAT3 Transcription Factor; Time Factors | 2021 |
Effect of artesunate on immune cells in ret-transgenic mouse melanoma model.
Topics: Animals; Antineoplastic Agents; Apoptosis; Artemisinins; Artesunate; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Killer Cells, Natural; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Transgenic; Proto-Oncogene Proteins c-ret; Skin Neoplasms; T-Lymphocytes, Regulatory | 2009 |